km.idaeo.ai · IDAEO 知識庫

🏛 本文屬於主題館「reports」 →

漱口水怎麼挑？牙周病該用哪一瓶？｜證據鏈

km 編輯部2026-08-13閱讀約 54 分鐘
#證據鏈#牙醫KM#牙周#兒童

本頁是〈漱口水怎麼挑？牙周病該用哪一瓶？〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

漱口水怎麼挑？牙周病該用哪一瓶？｜證據鏈

F-Units（事實單元帳）

  • F1｜confidence: verified｜basis: peer_reviewed（PMID 30968949，Cochrane 系統性回顧）｜period: 檢索至 2019-01-16，2019 刊出｜geo: universal｜span: 「As dental plaque is the primary cause, self-administered daily mechanical disruption and removal of plaque is important for oral health」「Toothbrushing can remove supragingival plaque on the facial and lingual/palatal surfaces, but special devices (such as floss, brushes, sticks, and irrigators) are often recommended to reach into the interdental area」「We included 35 RCTs (3929 randomised adult participants)」「Low-certainty evidence suggested that flossing, in addition to toothbrushing, may reduce gingivitis (measured by gingival index (GI)) at one month (SMD -0.58, 95% confidence interval (CI) -1.12 to -0.04; 8 trials, 585 participants), three months or six months」｜caveat: 多數受試者基線牙齦發炎程度低；作者評為低至極低確定性；無試驗評估牙縫蛀牙、多數未評估牙周炎
  • F2｜confidence: verified｜basis: clinical_guideline（PMID 25639948，第 11 屆歐洲牙周病學研討會第 1 組共識報告）｜period: 2015 刊出｜geo: universal｜span: 「an appropriate periodontal diagnosis is needed before submission of individuals to professional preventive measures and determines the selection of the type of preventive care」「preventive measures are not sufficient for treatment of periodontitis」「repeated and individualized oral hygiene instruction and professional mechanical plaque (and calculus) removal are important components of preventive programs」｜caveat: 共識報告，以修正版 GRADE 分級；為族群與臨床實務層級之建議，非個別病人之處方依據
  • F3｜confidence: verified｜basis: peer_reviewed（PMID 26113099，系統性回顧與統合分析）｜period: 檢索至 2014-07，2015 刊出｜geo: universal｜span: 「The panel included 72 articles on the effectiveness of SRP with or without the following: systemic antimicrobials, a systemic host modulator (subantimicrobial-dose doxycycline), locally delivered antimicrobials (chlorhexidine chips, doxycycline hyclate gel, and minocycline microspheres), and a variety of nonsurgical lasers」「the panel found approximately a 0.5-millimeter average improvement in CAL with SRP」「Combinations of SRP with assorted adjuncts resulted in a range of average CAL improvements between 0.2 and 0.6 mm over SRP alone」｜caveat: 族群為慢性牙周炎；所列輔助療法皆非漱口水；作者對多數輔助療法之效益確定性評為低
  • F4｜confidence: verified｜basis: peer_reviewed（PMID 33010026，系統性回顧與網絡統合分析）｜period: 檢索至 2020-05-31，2020 刊出｜geo: universal｜span: 「School of Dentistry, National Taiwan University, Taipei, Taiwan」「Twenty-two studies were included」「Significantly greater PPD reduction was achieved in chlorhexidine chip group (WMD: 0.65 mm, 95% CI: 0.21-1.10) and tetracycline fibre group (WMD: 0.64 mm, 95% CI: 0.20-1.08) over 6-month follow-up」「Adjunctive local antimicrobial agents achieved small additional PPD reduction and CAL gain in residual pockets for a follow-up of up to 6 months」｜caveat: 族群限支持性牙周治療期間仍有殘存囊袋者；介入為置入囊袋之局部投藥，漱口途徑不在該分析比較範圍內
  • F5｜confidence: verified｜basis: clinical_guideline（PMID 32383274，EFP S3 等級臨床實務指引）｜period: 2020 刊出｜geo: universal｜span: 「The S3 CPG approaches the treatment of periodontitis (stages I, II and III) using a pre-established stepwise approach to therapy that, depending on the disease stage, should be incremental, each including different interventions」「supra- and sub-gingival instrumentation, with and without adjunctive therapies」｜caveat: 指引全文為付費牆、本機未能取回，本條僅依 PubMed 摘要逐字引用，禁擴寫為指引全文內容；分期與介入之個別適用須由臨床判斷
  • F6｜confidence: verified｜basis: clinical_guideline（PMID 25683242，第 11 屆歐洲牙周病學研討會引言與目標報告）｜period: 2015 刊出｜geo: universal｜span: 「understanding the limitations of self-medication with oral health care products without a diagnosis of the underlying condition」「a need to communicate to the public the critical importance of gingival bleeding as an early sign of disease」｜caveat: 研討會層級之公共衛生建議，非個別用藥指示
  • F7｜confidence: verified｜basis: peer_reviewed（PMID 31869441，EFP 委託之系統性回顧與統合分析）｜period: 2020 刊出｜geo: universal｜span: 「Meta-analyses included 70 studies of adjunctive antiseptics」「Compared with mechanical plaque control alone, adjuncts yielded statistically significant reductions in gingival index (n = 72; SMD = -1.268; 95% CI [-1.489; -1.047]; p < .001; I2 = 96.2%)」「Mouthrinses resulted in greater reductions in per cent plaque compared with dentifrices (meta-regression, coefficient = 13.80%; 95% CI [2.40%; 25.10%]; p = .020)」「The antiseptic agents were similarly effective in reducing gingivitis and plaque in patients with dental plaque-induced gingivitis (intact periodontium) or previously treated periodontitis with gingival inflammation」｜caveat: 異質性極高（各項 I² 介於 95.1% 至 96.9%）；為 6 個月家用 RCT 之合成；統計顯著不等於個人可感知之差異
  • F8｜confidence: verified｜basis: peer_reviewed（PMID 25495592，系統性回顧與統合分析）｜period: 2015 刊出｜geo: universal｜span: 「87 articles with 133 comparisons, were included in the review」「formulations with specific agents for chemical plaque control provide statistically significant improvements in terms of gingival, bleeding and plaque indices」｜caveat: 作者於結論明言存在顯著異質性；為 6 個月居家使用 RCT 之合成
  • F9｜confidence: verified｜basis: peer_reviewed（PMID 28362061，Cochrane 系統性回顧）｜period: 檢索至 2016-09-28，2017 刊出｜geo: universal｜span: 「We included 51 studies that analysed a total of 5345 participants」「One study was assessed as being at unclear risk of bias, with the remaining 50 being at high risk of bias」「After 4 to 6 weeks of use, chlorhexidine mouthrinse reduced gingivitis (Gingival Index (GI) 0 to 3 scale) by 0.21 (95% CI 0.11 to 0.31) compared to placebo, control or no mouthrinse (10 trials, 805 participants with mild gingival inflammation (mean score 1 on the GI scale) analysed, high-quality evidence)」｜caveat: 效果量係在機械性口腔衛生之外的「額外」效果，非漱口水單獨使用之效果
  • F10｜confidence: verified｜basis: peer_reviewed（PMID 28362061，同上）｜period: 2017 刊出｜geo: universal｜span: 「Plaque was measured by different indices and the SMD at 4 to 6 weeks was 1.45 (95% CI 1.00 to 1.90) standard deviations lower in the chlorhexidine group (12 trials, 950 participants analysed, high-quality evidence), indicating a large reduction in plaque」｜caveat: 牙菌斑為替代指標，非臨床結果指標
  • F11｜confidence: verified｜basis: peer_reviewed（PMID 28362061，同上）｜period: 2017 刊出｜geo: universal｜span: 「a reduction in gingivitis in individuals with mild gingival inflammation on average (mean score of 1 on the 0 to 3 GI scale) that was not considered to be clinically relevant」「There is insufficient evidence to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with mean GI scores of 1.1 to 3 indicating moderate or severe levels of gingival inflammation」「There is no evidence that one concentration of chlorhexidine rinse is more effective than another」｜caveat: 「未達臨床意義」係針對輕度牙齦發炎族群之牙齦指數，不可外推為「無效」或「不必用」；亦不可外推為中重度族群之結論
  • F12｜confidence: verified｜basis: peer_reviewed（PMID 28362061，同上）｜period: 2017 刊出｜geo: universal｜span: 「There was a large increase in extrinsic tooth staining in participants using chlorhexidine mouthrinse at 4 to 6 weeks」「The SMD was 1.07 (95% CI 0.80 to 1.34) standard deviations higher (eight trials, 415 participants analysed, moderate-quality evidence) in the chlorhexidine mouthrinse group」「Rinsing with chlorhexidine mouthrinse for 4 weeks or longer causes extrinsic tooth staining」｜caveat: 外源性染色，非牙齒本質變色；本卡不就其可否清除或如何清除作任何宣稱
  • F13｜confidence: verified｜basis: peer_reviewed（PMID 28362061，同上）｜period: 2017 刊出｜geo: universal｜span: 「The adverse effects most commonly reported in the included studies were taste disturbance/alteration (reported in 11 studies), effects on the oral mucosa including soreness, irritation, mild desquamation and mucosal ulceration/erosions (reported in 13 studies) and a general burning sensation or a burning tongue or both (reported in nine studies)」「Results for the effect of chlorhexidine mouthrinse on calculus formation were inconclusive」｜caveat: 為納入研究之回報頻次，非發生率；多數研究未以偵測不良反應為主要設計
  • F14｜confidence: verified｜basis: peer_reviewed（PMID 35762364，系統性回顧與統合分析）｜period: 檢索至 2021-12-07，2022 刊出｜geo: universal｜span: 「Fourteen studies were deemed eligible for inclusion, reporting on a total of 602 patients with an age range of 11-35 years」「The experimental solution was a 0.06%, 0.12%, or 0.2% CHX mouthwash with the control either a placebo mouthwash or a selection from a variety of mouthwashes」「Treatment duration varied from 1 day to almost 5 months and the follow-up period varied from 1 min to 5 months」｜caveat: 族群限固定矯正裝置治療中者；治療與追蹤時間跨度大，不可視為長期使用之安全性證據
  • F15｜confidence: verified｜basis: peer_reviewed（PMID 26227646，統合分析）｜period: 納入 1980 至 2012 年試驗，2015 刊出｜geo: universal｜span: 「All industry-sponsored clinical trials investigating the antigingivitis and antiplaque effects of essential oil (EO)-containing mouthrinses conducted from 1980 to 2012 were reviewed; 29 of 32 studies met the inclusion criteria of 6 months or longer duration, randomized, observer-masked, placebo-controlled, and with individual-level site-specific data」「The summary percentage reductions in whole-mouth mean gingivitis and plaque at 6 months were 16.0 (95% CI, 11.3-20.7) and 27.7 (95% CI, 22.4-32.9), respectively」｜caveat: 納入條件即為業界贊助試驗，資助來源為解讀時必須揭露之限制；本卡不引用該文之產品層級用語
  • F16｜confidence: verified｜basis: peer_reviewed（PMID 27628316，統合分析與統合迴歸）｜period: 檢索至 2016-04，2016 刊出｜geo: universal｜span: 「From 3045 citations, 16 studies were included」「Mean QHI (WMD=-0.86, 95%CI -1.05 to -0.66) and MGI (WMD=-0.52, 95%CI -0.67 to -0.37) were lower for EO+MPC than placebo+MPC」「The analysis of risk of bias suggested that the quality of the studies ranged from moderate to low」「High heterogeneity (I2>95%) was found and explained」｜caveat: 該文另於「臨床意義」段落寫有產品層級之推薦式結論句，本卡依合規紅線不予引用、不予轉述、不予改寫
  • F17｜confidence: verified｜basis: peer_reviewed（PMID 33185736，系統性回顧與統合分析）｜period: 2021 刊出｜geo: universal｜span: 「Eight studies were included」「The meta-analysis demonstrated that groups that used CPC displayed a significantly greater reduction in the plaque index score (MD; 95% confidence interval [95%CI]: - 0.70; - 0.83 to - 0.57) and in the gingival index (MD; 95%CI: - 0.38; - 0.47 to - 0.28) when compared to placebo」「high heterogeneity was observed in both analyses (I2 = 89% and I2 = 98%, respectively)」「demonstrating the potential to compensate for the limitations of interproximal plaque control」｜caveat: 結果限牙縫面；原文數值為負值（代表下降），本卡以「下降 0.70」等中文表述並將區間依幅度大小排列，未改變數值本身；異質性極高，區間解讀須保守
  • F18｜confidence: verified｜basis: peer_reviewed（PMID 27472005，Cochrane 系統性回顧）｜period: 檢索至 2016-04-22，2016 刊出｜geo: universal｜span: 「In this review, we included 37 trials involving 15,813 children and adolescents」「All trials tested supervised use of fluoride mouthrinse in schools, with two studies also including home use」「Most studies (28) were at high risk of bias, and nine were at unclear risk of bias」「the D(M)FS pooled PF was 27% (95% confidence interval (CI), 23% to 30%; I(2) = 42%) (moderate quality evidence)」「The pooled estimate of D(M)FT PF was 23% (95% CI, 18% to 29%; I² = 54%)」「We found limited information concerning possible adverse effects or acceptability of the treatment regimen in the included trials」｜caveat: 效果係在學校監督情境下取得；作者說明結果或可適用於其他情境，但居家未受監督使用之防蛀效果大小較不明確
  • F19｜confidence: verified｜basis: clinical_guideline（PMID 24177407，ADA 科學事務委員會專家小組臨床建議）｜period: 檢索至 2012-10，2013 刊出｜geo: universal｜span: 「The panel recommends the following for people at risk of developing dental caries」「a prescription-strength, home-use 0.05 percent fluoride gel or paste or 0.09 percent fluoride mouthrinse for patients 6 years or older」「Only 2.26 percent fluoride varnish is recommended for children younger than 6 years」｜caveat: 建議適用對象為「有蛀牙風險者」，非全體人口；各國產品濃度、分類與可得性不同，須依所在地產品標示與牙醫師指示；該文另有勘誤（劑量誤植）記錄在案
  • F20｜confidence: verified｜basis: peer_reviewed（PMID 20091645，Cochrane 系統性回顧）｜period: 檢索至 2009-03-09，2010 刊出｜geo: universal｜span: 「A possible adverse effect associated with the use of topical fluoride is the development of dental fluorosis due to the ingestion of excessive fluoride by young children with developing teeth」「Children under the age of 6 years at the time topical fluorides were used」「25 studies were included: 2 RCTs, 1 cohort study, 6 case-control studies and 16 cross-sectional surveys」「Only one RCT was judged to be at low risk of bias」「There should be a balanced consideration between the benefits of topical fluorides in caries prevention and the risk of the development of fluorosis」｜caveat: 多數可得證據聚焦於輕度氟斑齒；該回顧已於 2024 年發布更新版，本卡數字取自 2010 年版，放量前應複查更新版是否改變結論
  • F21｜confidence: verified｜basis: peer_reviewed（PMID 36156769，Cochrane 系統性回顧）｜period: 檢索至 2021-09-28，2022 刊出｜geo: universal｜span: 「We included 49 trials with 6771 participants」「rinsing with chlorhexidine mouthrinses (0.12% and 0.2% concentrations) both before and 24 hours after extraction(s) substantially reduced the risk of developing dry socket with an OR of 0.38 (95% CI 0.25 to 0.58; P < 0.00001; 6 trials, 1547 participants; moderate-certainty evidence)」「The present review found some evidence for the association of minor adverse reactions with use of 0.12%, 0.2% chlorhexidine mouthrinses (alteration in taste, staining of teeth, stomatitis) though most studies were not designed explicitly to detect the presence of hypersensitivity reactions to mouthwash as part of the study protocol」「all but five studies included in the present review included participants undergoing extraction of third molars, most of which were undertaken by oral surgeons」｜caveat: 為醫囑期間之特定情境用法，非日常保養依據；6,771 人為全回顧受試者數，乾槽症預防之 chlorhexidine 漱口比較僅涵蓋 6 篇試驗 1,547 人
  • F22｜confidence: verified｜basis: peer_reviewed（PMID 31825092，Cochrane 系統性回顧）｜period: 檢索至 2019-04，2019 刊出｜geo: universal｜span: 「We included 44 trials in the review with 1809 participants comparing an intervention with a placebo or a control」「We excluded studies including patients with halitosis secondary to systemic disease and halitosis-masking interventions」「for mouthwash containing chlorhexidine and zinc acetate versus placebo mouthwash, the evidence was very uncertain for the outcome dentist-reported OLT scores (MD -0.20, 95% CI -0.58 to 0.18; 1 trial, 44 participants; very low-certainty evidence)」「We found low- to very low-certainty evidence to support the effectiveness of interventions for managing halitosis compared to placebo or control for the OLT and patient-reported outcomes tested」「We were unable to draw any conclusions regarding the superiority of any intervention or concentration」｜caveat: 多數為 1 至 4 週短期追蹤，僅 1 篇報告 3 個月結果；亦排除了重度牙周炎受試者
  • F23｜confidence: verified｜basis: peer_reviewed（PMID 31655832，系統性回顧）｜period: 2020 刊出｜geo: universal｜span: 「8 studies were included in the qualitative analysis which include a total of 43,499 subjects: two meta-analyses, a clinical trial, three case-control studies and two cohort studies」「It cannot be guaranteed that the use of mouthwash represents an independent risk factor for the development of head and neck cancer」「the risk does increase when it occurs in association with other carcinogenic risk factors」｜caveat: 質性合成、未做統合分析；納入研究之結果不一致（1 篇找到關聯、2 篇在高使用頻率下找到關聯、3 篇未找到關聯）
  • F24｜confidence: verified｜basis: peer_reviewed（PMID 29411737，個案報告與系統性文獻回顧）｜period: 2018 刊出｜geo: universal｜span: 「Several cases of allergic reactions to chlorhexidine have been reported, both in the general population and in workers」「Our systematic literature review identified 14 cases of occupational chlorhexidine-induced allergy among HCWs; in these cases, the clinical presentation was mild and the symptoms resolved」｜caveat: 族群為職業暴露之醫護人員，不可外推為一般漱口使用者之發生率；該回顧僅納入職業性個案報告與系列，無分母、無法計算風險
  • F25｜confidence: verified｜basis: peer_reviewed（PMID 35998741，系統性回顧與統合分析）｜period: 檢索 2000-01 至 2022-01，2022 刊出｜geo: universal｜span: 「A total of 20 studies were included in the meta-analysis」「The prevalence of periodontitis among pregnancy was 40% (95% Confidence Interval (CI): [0.15, 1.00])」「the prevalence rates of BOP (+) and PD≥4 mm presented a gradual increase throughout pregnancy」「However, heterogeneity was high among included studies」｜caveat: 信賴區間極寬（0.15 至 1.00）、異質性高，該合併盛行率僅供方向性理解，不可當作任一國家或族群之估計值
  • F26｜confidence: verified｜basis: peer_reviewed（PMID 28605006，Cochrane 系統性回顧）｜period: 檢索至 2016-10，2017 刊出｜geo: universal｜span: 「gum conditions tend to worsen during pregnancy」「There were 15 RCTs (n = 7161 participants) meeting our inclusion criteria」「All the included studies were at high risk of bias mostly due to lack of blinding and imbalance in baseline characteristics of participants」「It is not clear if periodontal treatment during pregnancy has an impact on preterm birth (low-quality evidence)」「There is low-quality evidence that periodontal treatment may reduce low birth weight (< 2500 g), however, our confidence in the effect estimate is limited」｜caveat: 本條為「牙周治療」之證據，非「漱口水」之證據，不可互相代入
  • F27｜confidence: verified｜basis: peer_reviewed（PMID 26876277，系統性回顧）｜period: 檢索至 2015-02，2017 刊出｜geo: universal｜span: 「Of the total 206 articles searched, three randomized controlled trials evaluating neem-based herbal mouthrinses were included」「These studies reported that neem mouthrinse was as effective as chlorhexidine mouthrinse when used as an adjunct to toothbrushing in reducing plaque and gingival inflammation in gingivitis patients」「the quality of reporting and evidence along with methods of studies was generally flawed with unclear risk of bias」「the evidence concerning the clinical use of neem mouthrinses is lacking and needs further reinforcement with high-quality randomized controlled trials」｜caveat: 僅 3 篇 RCT、異質性明顯故未做統合分析；效果與 chlorhexidine 相當一說係納入研究之報告內容，非高確定性結論
  • F28｜confidence: verified｜basis: peer_reviewed（PMID 32383334，系統性回顧與統合分析）｜period: 檢索至 2020-04，2020 刊出｜geo: universal｜span: 「Seven RCTs were included」「significant heterogeneity for both GI (χ2 = 72.77, P < .0001, I2 = 91.76%) and PI (χ2 = 153.67, P < .0001, I2 = 96.10%) was observed between both TRP-MW and CHX-MW groups」「The overall mean difference for both GI (WMD = -0.29, 95% CI = -0.40 to -0.17, P < .001) and PI (WMD = -0.43, 95% CI = -0.54 to -0.31, P < .001) was statistically significant between TRP-MW and CHX-MW at follow-up, respectively」｜caveat: 異質性極高（I² 逾 90%），合併估計之解讀須極度保守；本卡不引用該文關於成本與可得性之描述
  • F29｜confidence: verified｜basis: internal_dataset｜period: 2025-03 至 2026-08 GSC｜geo: universal｜span: backlog #6「漱口水推薦」等 7 詞項合計曝光 272,409，來源站（1 站）｜caveat: 曝光為資產級數字，非去重流量；本條於發布轉檔時整條剝除，改以一句「本題選題依據為內部搜尋資料分析」代之
  • F30｜confidence: 結構性整理（編輯框架，非外部事實宣稱）｜basis: editorial_framework｜period: 2026-08-06｜geo: universal｜span: 「四路分流（預防蛀牙／牙齦發炎／已診斷牙周病／口臭）」「先講取代不了什麼、再講成分、末段講誰不適合」的敘事順序，以及「診斷→機械性治療→輔助抗菌」三步驟的排列方式，為本站依 F1 至 F28 文獻整理的溝通用架構｜caveat: 非臨床判準、非診斷工具、非產品選購指南，不取代牙醫師評估

來源清單

取用日期均為 2026-08-06；PubMed 條目以 E-utilities efetch 取得摘要原文逐字對照，全卡 F-Unit 英文 span 已以 `km-gate.py --spans` 回丟原文逐字比對。付費牆全文未取回者（F5 之指引全文）僅依摘要引用，已於該條 caveat 註明。

  1. Worthington HV, et al. Home use of interdental cleaning devices, in addition to toothbrushing, for preventing and controlling periodontal diseases and dental caries. Cochrane Database Syst Rev. 2019. PMID 30968949
  2. Tonetti MS, et al. Principles in prevention of periodontal diseases: Consensus report of group 1 of the 11th European Workshop on Periodontology. J Clin Periodontol. 2015. PMID 25639948
  3. Smiley CJ, et al. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015. PMID 26113099
  4. Wang CY, et al. Adjunctive local treatments for patients with residual pockets during supportive periodontal care: A systematic review and network meta-analysis. J Clin Periodontol. 2020. PMID 33010026
  5. Sanz M, et al. Treatment of stage I-III periodontitis — The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020. PMID 32383274
  6. Tonetti MS, et al. Primary and secondary prevention of periodontal and peri-implant diseases: Introduction to, and objectives of the 11th European Workshop on Periodontology consensus conference. J Clin Periodontol. 2015. PMID 25683242
  7. Figuero E, et al. Efficacy of adjunctive therapies in patients with gingival inflammation: A systematic review and meta-analysis. J Clin Periodontol. 2020. PMID 31869441
  8. Serrano J, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis. J Clin Periodontol. 2015. PMID 25495592
  9. James P, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev. 2017. PMID 28362061（對應 F9、F10、F11、F12、F13）
  10. Karamani I, et al. Chlorhexidine Mouthwash for Gingivitis Control in Orthodontic Patients: A Systematic Review and Meta-Analysis. Oral Health Prev Dent. 2022. PMID 35762364
  11. Araujo MWB, et al. Meta-analysis of the effect of an essential oil-containing mouthrinse on gingivitis and plaque. J Am Dent Assoc. 2015. PMID 26227646
  12. Haas AN, et al. Essential oils-containing mouthwashes for gingivitis and plaque: Meta-analyses and meta-regression. J Dent. 2016. PMID 27628316
  13. Langa GPJ, et al. The effect of cetylpyridinium chloride mouthrinse as adjunct to toothbrushing compared to placebo on interproximal plaque and gingival inflammation — a systematic review with meta-analyses. Clin Oral Investig. 2021. PMID 33185736
  14. Marinho VC, et al. Fluoride mouthrinses for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2016. PMID 27472005
  15. Weyant RJ, et al. Topical fluoride for caries prevention: executive summary of the updated clinical recommendations and supporting systematic review. J Am Dent Assoc. 2013. PMID 24177407
  16. Wong MC, et al. Topical fluoride as a cause of dental fluorosis in children. Cochrane Database Syst Rev. 2010. PMID 20091645
  17. Daly BJ, et al. Local interventions for the management of alveolar osteitis (dry socket). Cochrane Database Syst Rev. 2022. PMID 36156769
  18. Kumbargere Nagraj S, et al. Interventions for managing halitosis. Cochrane Database Syst Rev. 2019. PMID 31825092
  19. Ustrell-Borràs M, et al. Alcohol-based mouthwash as a risk factor of oral cancer: A systematic review. Med Oral Patol Oral Cir Bucal. 2020. PMID 31655832
  20. Toletone A, et al. Chlorhexidine-induced anaphylaxis occurring in the workplace in a health-care worker: case report and review of the literature. Med Lav. 2018. PMID 29411737
  21. Chen P, et al. Prevalence of periodontal disease in pregnancy: A systematic review and meta-analysis. J Dent. 2022. PMID 35998741
  22. Iheozor-Ejiofor Z, et al. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst Rev. 2017. PMID 28605006
  23. Dhingra K, Vandana KL. Effectiveness of Azadirachta indica (neem) mouthrinse in plaque and gingivitis control: a systematic review. Int J Dent Hyg. 2017. PMID 26876277
  24. AlJameel AH, Almalki SA. Effect of triphala mouthrinse on plaque and gingival inflammation: A systematic review and meta-analysis of randomized controlled trials. Int J Dent Hyg. 2020. PMID 32383334
  25. 內部數據：`analysis/reports/km-dental-backlog.md` #6 附錄（詞×站×曝光逐筆可對帳）
  26. 編輯框架：本站「四路分流」與敘事順序（無外部來源，標示為結構性整理）

內部引用鏈

  • 牙齦紅腫流血該怎麼分級、什麼情況要就醫：牙齦腫痛怎麼快速消？什麼情況要就醫？（KM-DENTAL-05）
  • 拔牙傷口的癒合節奏與乾槽症警訊：拔牙的洞要多久才會長好？（KM-DENTAL-01）
  • 蛀牙的成因與處理（含氟漱口水針對的目標）：蛀牙了一定要補嗎？補牙怎麼補？（KM-DENTAL-12）
發布閘門提醒：本卡為 draft。四語（zh-Hans／en／ja）未產前不得進 km_entries；F29（internal_dataset）與 frontmatter 之合計曝光欄於發布轉檔時剝除；F5 指引全文未取回前，該條維持「僅依摘要」定位，禁擴寫成指引全文內容；F20 之 Cochrane 已有 2024 年更新版，放量或改版前應複查更新版是否改變結論。

FAQ

用漱口水可以不用刷牙或不用牙線嗎？
**文獻裡沒有這個選項。** 牙菌斑是主要成因，每天以機械方式移除牙菌斑是基礎；刷牙處理得到牙齒的頰側與舌／顎側，牙縫則通常需要牙線、牙間刷等工具才觸及得到 [F1]。本卡引用的漱口水研究，都是把漱口水當成機械性清潔的「輔助」來檢驗其額外效果 [F7][F8]。在刷牙之外加上牙線，低確定性證據顯示可能在 1 個月、3 個月與 6 個月降低牙齦指數 [F1]。
洗口液を使えば歯みがきやフロスは不要ですか？ — **不要にはなりません。** 毎日の機械的歯垢除去が基礎です。歯みがきは頬側と舌側／口蓋側を扱い、歯間部には通常フロスや歯間ブラシが必要です [F1]。本カードの洗口液研究は、機械的清掃への上乗せ効果を検証しています [F7][F8]。フロス追加は 1、3、6 か月の歯肉指数を低下させる可能性がありますが、確実性は低いものです [F1]。
Can I use mouthwash instead of brushing or flossing? — **No.** Daily mechanical plaque removal is foundational. Brushing reaches facial and lingual/palatal surfaces; interdental areas usually need floss or interdental brushes [F1]. The mouthwash studies here test an additional effect on top of mechanical cleaning [F7][F8]. Adding floss to brushing may reduce gingivitis at 1, 3, and 6 months, with low-certainty evidence [F1].
牙周病用抗菌漱口水就會好嗎？
**不會，而且順序反了。** EFP 共識報告寫明預防性措施不足以用來治療牙周炎 [F2]；EFP 的 S3 等級臨床指引採階梯式流程，其中一組建議即針對牙齦上與牙齦下的器械清創，並明列「加上或不加上輔助療法」[F5]。效果量上，SRP 本身帶來約 0.5 毫米的臨床附著水準改善，各式輔助再多加 0.2 至 0.6 毫米 [F3]；而在殘存囊袋上有小幅額外效果的是置入囊袋的局部投藥製劑（chlorhexidine 晶片 0.65 毫米、四環黴素纖維 0.64 毫米）[F4]。須由牙醫師診斷與評估。
歯周病は抗菌洗口液で治りますか？ — **治りません。順番が逆です。** 予防措置は歯周炎治療に不十分です [F2]。EFP 指針は歯肉縁上・縁下の器械的デブライドメントを中心とする段階的治療で、補助療法は追加可能ですが代替ではありません [F5]。SRP は平均約 0.5 mm の CAL 改善、補助療法は 0.2〜0.6 mm の追加改善で、残存ポケットの小さな追加効果は chlorhexidine チップ 0.65 mm とテトラサイクリン線維 0.64 mm でした [F3][F4]。診断と評価が必要です。
Will an antimicrobial mouthwash cure periodontal disease? — **No; that reverses the required sequence.** Preventive measures are insufficient to treat periodontitis [F2]. EFP guidance uses stepwise treatment centred on supra- and subgingival instrumentation, with or without adjunctive therapies [F5]. SRP averages about 0.5 mm CAL improvement; adjuncts add 0.2 to 0.6 mm, while the small residual-pocket effects cited concern locally delivered chlorhexidine chips (0.65 mm) and tetracycline fibres (0.64 mm) [F3][F4]. Dental diagnosis and assessment are required.
chlorhexidine 漱口水可以一直用下去嗎？
**Cochrane 記錄的代價指向「不宜自行長期使用」。** 該回顧的結論句寫明使用 4 週或更久會造成外源性牙齒染色（4 至 6 週時標準化平均差 1.07）[F12]；納入研究中常見的其他不良反應包括味覺干擾（11 篇）、口腔黏膜疼痛刺激與潰瘍糜爛（13 篇）、灼熱感（9 篇）[F13]。同一份回顧也指出沒有證據顯示某一濃度優於另一濃度，且對中重度牙齦發炎者的效果證據不足 [F11]。濃度、頻率與使用期間應由牙醫師依診斷指示；在沒有診斷的情況下自我用藥有其限制 [F6]。
chlorhexidine 洗口液はずっと使えますか？ — **記録された代償は、自己判断の長期使用を支持しません。** 4 週間以上で外因性歯牙着色が起こり、4〜6 週で標準化平均差は 1.07 でした [F12]。味覚異常（11 研究）、粘膜への影響（13 研究）、灼熱感（9 研究）も多く報告されました [F13]。特定濃度の優越性は示されず、中等度〜重度歯肉炎への証拠も不十分です [F11]。濃度、頻度、期間は歯科医師が決めます [F6]。
Can I keep using chlorhexidine mouthwash indefinitely? — **The documented trade-offs point against unsupervised long-term use.** Rinsing for 4 weeks or longer causes extrinsic tooth staining, with SMD 1.07 at 4 to 6 weeks [F12]. Other commonly reported effects were taste disturbance (11 studies), oral-mucosal effects including soreness, irritation, ulceration or erosions (13 studies), and burning sensation (9 studies) [F13]. No concentration has evidence of superiority, and evidence is insufficient for moderate-to-severe gingival inflammation [F11]. A dentist should set concentration, frequency, and duration [F6].

來源錨定

引用本文

km 編輯部・《漱口水怎麼挑？牙周病該用哪一瓶？｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/reports/dental-mouthwash-selection-evidence

相關文章

更新 2026-08-13T14:17:27.409Z · server-rendered · four-language · IDAEO 知識庫